Relactorilante Kristalline Formen
EP4810495
23. September 2026
Anmelder: CURIA SPAIN, S.A.U. 🇪🇸
Details
- Veröffentlichungs-Nr.
- EP4810495
- Anmeldetag
- 19. März 2025
- Veröffentlichung
- 23. September 2026
- Rechtsraum
- EP
Abstract
The present invention relates to crystal solid forms of relacorilant, described herein as crystalline form I and form II, methods for preparing the same, pharmaceutical compositions containing them and their use in medicine, particularly for the treatment and/or prevention of Cushing's syndrome, solid tumors or alcoholism.
Anmelder
- Firma
- CURIA SPAIN, S.A.U.
- Land
- 🇪🇸 Spanien